Literature DB >> 3420441

Neonatal withdrawal symptoms after chronic maternal ingestion of caffeine.

J D McGowan1, R E Altman, W P Kanto.   

Abstract

We have identified eight infants born to mothers who were heavy users of caffeine during pregnancy. These infants exhibited unusual behavior in the immediate newborn period. Predominant symptoms were irritability, jitteriness, and vomiting. The eight infants had extensive diagnostic studies and none of the usual causes for their symptoms were identified. Caffeine was present in the serum of six infants, and three of the six infants had caffeine in their urine. The symptoms resolved spontaneously. We hypothesize that these infants were exposed to high maternal levels of caffeine for the majority of the pregnancy, resulting in a withdrawal syndrome after delivery.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3420441     DOI: 10.1097/00007611-198809000-00006

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  4 in total

Review 1.  A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features.

Authors:  Laura M Juliano; Roland R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  2004-09-21       Impact factor: 4.530

Review 2.  Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity.

Authors:  Katherine Schoen; Tian Yu; Chris Stockmann; Michael G Spigarelli; Catherine M T Sherwin
Journal:  Paediatr Drugs       Date:  2014-04       Impact factor: 3.022

3.  Long-term effects of neonatal exposure to isobutylmethylxanthine. I. Retardation of learning with antagonism by mianserin.

Authors:  B S Neal; S B Sparber
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  Heavy caffeine intake in pregnancy and sudden infant death syndrome. New Zealand Cot Death Study Group.

Authors:  R P Ford; P J Schluter; E A Mitchell; B J Taylor; R Scragg; A W Stewart
Journal:  Arch Dis Child       Date:  1998-01       Impact factor: 3.791

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.